a549 luc cells Search Results


a549 cell line  (AMS Biotechnology)
96
AMS Biotechnology a549 cell line
a Relative viability of <t>A549</t> cells treated with 0–30 µL of TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. b Representative images of Live/Dead staining of A549 cells at 24 and 48 h with 0,10, 20 and 30 µL of TGel (i–iv, respectively). Live cells stained green, dead cells stained red. Magnification, ×10. Scale bar, 200 µm. c Flow cytometric analysis of apoptosis of Medium (left, top) and TGel (right, top) treated A549 cells for 24 h in vitro. Proportion of live, early apoptotic, late apoptotic/necrotic cells treated with Medium or TGel (bottom). Q 1 = early apoptotic cells, Q 2 and Q 4 = late apoptotic/necrotic cells and Q 3 = live cells ( n = 2). Significance within treatment groups was determined using an unpaired t test. * = p < 0.05, ** = p < 0.01. d Relative viability of Balb/c 3T3 clone A31 cells treated with TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
A549 Cell Line, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549 cell line/product/AMS Biotechnology
Average 96 stars, based on 1 article reviews
a549 cell line - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
nf b transcription factor  (BPS Bioscience)
93
BPS Bioscience nf b transcription factor
a Relative viability of <t>A549</t> cells treated with 0–30 µL of TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. b Representative images of Live/Dead staining of A549 cells at 24 and 48 h with 0,10, 20 and 30 µL of TGel (i–iv, respectively). Live cells stained green, dead cells stained red. Magnification, ×10. Scale bar, 200 µm. c Flow cytometric analysis of apoptosis of Medium (left, top) and TGel (right, top) treated A549 cells for 24 h in vitro. Proportion of live, early apoptotic, late apoptotic/necrotic cells treated with Medium or TGel (bottom). Q 1 = early apoptotic cells, Q 2 and Q 4 = late apoptotic/necrotic cells and Q 3 = live cells ( n = 2). Significance within treatment groups was determined using an unpaired t test. * = p < 0.05, ** = p < 0.01. d Relative viability of Balb/c 3T3 clone A31 cells treated with TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
Nf B Transcription Factor, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nf b transcription factor/product/BPS Bioscience
Average 93 stars, based on 1 article reviews
nf b transcription factor - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
a549-nfκb-re-luc stable transfected cells  (Signosis Inc)
90
Signosis Inc a549-nfκb-re-luc stable transfected cells
a Relative viability of <t>A549</t> cells treated with 0–30 µL of TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. b Representative images of Live/Dead staining of A549 cells at 24 and 48 h with 0,10, 20 and 30 µL of TGel (i–iv, respectively). Live cells stained green, dead cells stained red. Magnification, ×10. Scale bar, 200 µm. c Flow cytometric analysis of apoptosis of Medium (left, top) and TGel (right, top) treated A549 cells for 24 h in vitro. Proportion of live, early apoptotic, late apoptotic/necrotic cells treated with Medium or TGel (bottom). Q 1 = early apoptotic cells, Q 2 and Q 4 = late apoptotic/necrotic cells and Q 3 = live cells ( n = 2). Significance within treatment groups was determined using an unpaired t test. * = p < 0.05, ** = p < 0.01. d Relative viability of Balb/c 3T3 clone A31 cells treated with TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
A549 Nfκb Re Luc Stable Transfected Cells, supplied by Signosis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549-nfκb-re-luc stable transfected cells/product/Signosis Inc
Average 90 stars, based on 1 article reviews
a549-nfκb-re-luc stable transfected cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
a549-luc-mir-193a-3p cells  (GenScript corporation)
90
GenScript corporation a549-luc-mir-193a-3p cells
a Relative viability of <t>A549</t> cells treated with 0–30 µL of TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. b Representative images of Live/Dead staining of A549 cells at 24 and 48 h with 0,10, 20 and 30 µL of TGel (i–iv, respectively). Live cells stained green, dead cells stained red. Magnification, ×10. Scale bar, 200 µm. c Flow cytometric analysis of apoptosis of Medium (left, top) and TGel (right, top) treated A549 cells for 24 h in vitro. Proportion of live, early apoptotic, late apoptotic/necrotic cells treated with Medium or TGel (bottom). Q 1 = early apoptotic cells, Q 2 and Q 4 = late apoptotic/necrotic cells and Q 3 = live cells ( n = 2). Significance within treatment groups was determined using an unpaired t test. * = p < 0.05, ** = p < 0.01. d Relative viability of Balb/c 3T3 clone A31 cells treated with TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
A549 Luc Mir 193a 3p Cells, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549-luc-mir-193a-3p cells/product/GenScript corporation
Average 90 stars, based on 1 article reviews
a549-luc-mir-193a-3p cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
luciferase-transfected bioluminescent a549 cells  (Xenogen Corporation)
90
Xenogen Corporation luciferase-transfected bioluminescent a549 cells
a Relative viability of <t>A549</t> cells treated with 0–30 µL of TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. b Representative images of Live/Dead staining of A549 cells at 24 and 48 h with 0,10, 20 and 30 µL of TGel (i–iv, respectively). Live cells stained green, dead cells stained red. Magnification, ×10. Scale bar, 200 µm. c Flow cytometric analysis of apoptosis of Medium (left, top) and TGel (right, top) treated A549 cells for 24 h in vitro. Proportion of live, early apoptotic, late apoptotic/necrotic cells treated with Medium or TGel (bottom). Q 1 = early apoptotic cells, Q 2 and Q 4 = late apoptotic/necrotic cells and Q 3 = live cells ( n = 2). Significance within treatment groups was determined using an unpaired t test. * = p < 0.05, ** = p < 0.01. d Relative viability of Balb/c 3T3 clone A31 cells treated with TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
Luciferase Transfected Bioluminescent A549 Cells, supplied by Xenogen Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luciferase-transfected bioluminescent a549 cells/product/Xenogen Corporation
Average 90 stars, based on 1 article reviews
luciferase-transfected bioluminescent a549 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
luc-a549  (GenTarget)
90
GenTarget luc-a549
a Relative viability of <t>A549</t> cells treated with 0–30 µL of TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. b Representative images of Live/Dead staining of A549 cells at 24 and 48 h with 0,10, 20 and 30 µL of TGel (i–iv, respectively). Live cells stained green, dead cells stained red. Magnification, ×10. Scale bar, 200 µm. c Flow cytometric analysis of apoptosis of Medium (left, top) and TGel (right, top) treated A549 cells for 24 h in vitro. Proportion of live, early apoptotic, late apoptotic/necrotic cells treated with Medium or TGel (bottom). Q 1 = early apoptotic cells, Q 2 and Q 4 = late apoptotic/necrotic cells and Q 3 = live cells ( n = 2). Significance within treatment groups was determined using an unpaired t test. * = p < 0.05, ** = p < 0.01. d Relative viability of Balb/c 3T3 clone A31 cells treated with TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
Luc A549, supplied by GenTarget, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luc-a549/product/GenTarget
Average 90 stars, based on 1 article reviews
luc-a549 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


a Relative viability of A549 cells treated with 0–30 µL of TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. b Representative images of Live/Dead staining of A549 cells at 24 and 48 h with 0,10, 20 and 30 µL of TGel (i–iv, respectively). Live cells stained green, dead cells stained red. Magnification, ×10. Scale bar, 200 µm. c Flow cytometric analysis of apoptosis of Medium (left, top) and TGel (right, top) treated A549 cells for 24 h in vitro. Proportion of live, early apoptotic, late apoptotic/necrotic cells treated with Medium or TGel (bottom). Q 1 = early apoptotic cells, Q 2 and Q 4 = late apoptotic/necrotic cells and Q 3 = live cells ( n = 2). Significance within treatment groups was determined using an unpaired t test. * = p < 0.05, ** = p < 0.01. d Relative viability of Balb/c 3T3 clone A31 cells treated with TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

Journal: British Journal of Cancer

Article Title: Evaluation of the activity of a chemo-ablative, thermoresponsive hydrogel in a murine xenograft model of lung cancer

doi: 10.1038/s41416-020-0904-9

Figure Lengend Snippet: a Relative viability of A549 cells treated with 0–30 µL of TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. b Representative images of Live/Dead staining of A549 cells at 24 and 48 h with 0,10, 20 and 30 µL of TGel (i–iv, respectively). Live cells stained green, dead cells stained red. Magnification, ×10. Scale bar, 200 µm. c Flow cytometric analysis of apoptosis of Medium (left, top) and TGel (right, top) treated A549 cells for 24 h in vitro. Proportion of live, early apoptotic, late apoptotic/necrotic cells treated with Medium or TGel (bottom). Q 1 = early apoptotic cells, Q 2 and Q 4 = late apoptotic/necrotic cells and Q 3 = live cells ( n = 2). Significance within treatment groups was determined using an unpaired t test. * = p < 0.05, ** = p < 0.01. d Relative viability of Balb/c 3T3 clone A31 cells treated with TGel for 24 and 48 h ( n = 3). Significance was determined using a two-way ANOVA, with Tukey's multiple comparisons test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

Article Snippet: An A549 cell line expressing firefly luc with puromycin resistance (SC043-luc) was purchased from AMS Biotechnology (Abingdon, UK).

Techniques: Staining, In Vitro

a Representative overlay images of bioluminescent A549-luc cells post intratumoural administration of 100 µL of fluorescently tagged TGel at Day 0. Blue represents bioluminescent signal from A549-luc cells, Yellow represents fluorescent signal from TGel. b Representative fluorescent images at Day 0 (top) and Day 14 (bottom) post intratumoural administration of saline (left) or TGel (right). c Representative images (greyscale photograph [left], fluorescent signal [centre] and overlay [right]) of saline (top) or TGel (bottom) treated tumours excised on Day 14 post intratumoural administration.

Journal: British Journal of Cancer

Article Title: Evaluation of the activity of a chemo-ablative, thermoresponsive hydrogel in a murine xenograft model of lung cancer

doi: 10.1038/s41416-020-0904-9

Figure Lengend Snippet: a Representative overlay images of bioluminescent A549-luc cells post intratumoural administration of 100 µL of fluorescently tagged TGel at Day 0. Blue represents bioluminescent signal from A549-luc cells, Yellow represents fluorescent signal from TGel. b Representative fluorescent images at Day 0 (top) and Day 14 (bottom) post intratumoural administration of saline (left) or TGel (right). c Representative images (greyscale photograph [left], fluorescent signal [centre] and overlay [right]) of saline (top) or TGel (bottom) treated tumours excised on Day 14 post intratumoural administration.

Article Snippet: An A549 cell line expressing firefly luc with puromycin resistance (SC043-luc) was purchased from AMS Biotechnology (Abingdon, UK).

Techniques: